Certuma Expands Into Argentina With US$10 Million Seed Round

Certuma, the clinical artificial intelligence startup founded in December 2025 by Argentine-Spanish entrepreneur Martín Varsavsky in Austin, Texas, has begun operations in Argentina after securing a US$10 million seed round led by 8VC. The company is using its entry into the country as the starting point for a broader Latin American expansion focused on AI-powered clinical assistance.

Certuma enters Argentina with a US$10 million seed round

The company's arrival in the region follows its seed financing led by 8VC, the venture capital firm co-founded by Joe Lonsdale, who also co-founded Palantir alongside Peter Thiel.

Leading Certuma's expansion across Latin America is Bruno Marino, the company's Head of LATAM, who is responsible for driving its regional growth strategy.

Certuma brings together Varsavsky's more than three decades of experience as a serial entrepreneur with a focus on regulated medical technology and the emerging capabilities of clinical artificial intelligence.

Varsavsky has founded more than ten companies, including Jazztel and Viatel  in telecommunications, Goggo Network in autonomous mobility, and Prelude Fertility, Overture Life and Gameto in reproductive health. Gameto already has an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration and is currently in Phase 3.

With Certuma, that background in regulated healthcare technology is being applied to the development of a new generation of clinical AI tools.

An AI copilot designed to give physicians more time

At the center of Certuma's technology is MedCanon, the company's proprietary clinical reasoning engine. The technology powers Certuma Copilot, an artificial intelligence assistant designed to support physicians throughout the clinical workflow.

The tool records and organizes information during medical consultations, assists with clinical reasoning and automates administrative tasks that can take up a significant portion of physicians' time.

In Argentina, diagnosis and prescribing remain exclusive responsibilities of licensed physicians. Certuma therefore operates strictly as an assistant and does not make clinical decisions.

“We are not looking to replace the physician. The final decision and signature remain with the professional. We believe the value of AI lies in expanding physicians' capacity and giving them back time for cases where their experience is indispensable,” said Bruno Marino, Head of LATAM at Certuma.

A similar model is already being used in the United States. The Permanente Medical Group, part of Kaiser Permanente, documents more than 2.5 million annual uses of similar tools and reports savings of more than 15,700 hours of medical documentation.

A growing need for clinical AI in Latin America

Certuma's expansion comes as healthcare systems across Latin America face significant workforce challenges. The Pan American Health Organization projects a shortage of between 600,000 and 2 million healthcare workers in Latin America by 2030.

Argentina faces additional pressures, including the concentration of medical centers in Buenos Aires and an increase in vacancies in medical residency programs. Against this backdrop, clinical AI can serve as a tool to increase the operational capacity of healthcare teams.

The global market for AI-powered clinical documentation was valued at US$1.23 billion in 2025 and could reach US$12.78 billion by 2035, representing a compound annual growth rate of 26%.

Certuma advances its regulatory strategy

With the US$10 million seed round, Certuma is advancing on two regulatory fronts simultaneously.

The company is working toward FDA approval in the United States while also pursuing homologation with ANMAT in Argentina. At the same time, it is scaling its platform and strengthening its clinical infrastructure with the goal of serving healthcare institutions across Latin America.

The launch in Argentina marks the next stage in Certuma's development as it combines clinical artificial intelligence, regulated medical technology and a regional expansion strategy aimed at supporting physicians and healthcare institutions.